CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 64 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $178,000 | -76.1% | 84,357 | -67.3% | 0.00% | – |
| Q1 2021 | $745,000 | +19.6% | 257,742 | -11.4% | 0.00% | – |
| Q4 2020 | $623,000 | -65.7% | 290,850 | -0.9% | 0.00% | – |
| Q3 2020 | $1,817,000 | +82.8% | 293,422 | +89.8% | 0.00% | – |
| Q2 2020 | $994,000 | +209.7% | 154,587 | +99.8% | 0.00% | – |
| Q1 2020 | $321,000 | -24.8% | 77,384 | +7.1% | 0.00% | – |
| Q4 2019 | $427,000 | +36.0% | 72,246 | +24.2% | 0.00% | – |
| Q3 2019 | $314,000 | -22.5% | 58,159 | +15.9% | 0.00% | – |
| Q2 2019 | $405,000 | +77.6% | 50,193 | +74.7% | 0.00% | – |
| Q1 2019 | $228,000 | +212.3% | 28,735 | +71.6% | 0.00% | – |
| Q4 2018 | $73,000 | – | 16,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eversept Partners, LP | 522,042 | $1,117,170 | 0.13% |
| XTX MARKETS LLC | 26,041 | $56,000 | 0.12% |
| Samsara BioCapital, LLC | 300,000 | $642,000 | 0.06% |
| Ikarian Capital, LLC | 650,000 | $1,392,000 | 0.06% |
| Opaleye Management Inc. | 187,750 | $402,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 108,026 | $231,000 | 0.04% |
| Anson Funds Management LP | 97,601 | $209,000 | 0.04% |
| Virtu Financial LLC | 83,221 | $178,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 47,084 | $101,000 | 0.02% |
| WEXFORD CAPITAL LP | 19,512 | $42,000 | 0.01% |